Atlas Trials

A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia

Clinical trial NCT03359785 · COMPLETED

Trial details

NCT number
NCT03359785
Sponsor
Neurocrine Biosciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2018-01-10
Primary completion
2020-12-21
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.